This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Other. Active years: 2016.
Company Filing History:
1 out of 834,350 Years Active: 2016
Title: David A. Knorr: Innovator in Stem Cell Research
Introduction
David A. Knorr is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of stem cell research, particularly in the development of natural killer (NK) cells. His innovative methods have the potential to impact treatments for cancer and infectious diseases.
Latest Patents
David A. Knorr holds a patent for a "Method for developing natural killer cells from stem cells." This patent describes a method for producing NK cells from pluripotent stem cells. The process includes culturing pluripotent stem cells in a first serum-free medium, aggregating the undifferentiated stem cells to form embryoid bodies, and culturing these bodies to produce hematopoietic precursor cells. The precursor cells are then cultured in a serum-free medium to produce NK cells. The patent also outlines methods for using these NK cells in therapeutic applications.
Career Highlights
Throughout his career, David A. Knorr has worked in various capacities that have allowed him to advance his research. He has collaborated with notable professionals in the field, enhancing his contributions to stem cell technology.
Collaborations
Some of his coworkers include Dan Samuel Kaufman and Dan S. Kaufman. Their collaborative efforts have furthered the understanding and application of stem cell-derived NK cells.
Conclusion
David A. Knorr's work in developing methods for producing natural killer cells from stem cells represents a significant advancement in medical research. His contributions have the potential to lead to innovative treatments for serious health conditions.